FDA notifications. Tenofovir in India receives tentative approval.
D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D015658:HIV Infections / Q000188:drug therapy; D007194:India; D063065:Organophosphonates / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors; D000068698:Tenofovir; D014481:United States; D014486:United States Food and Drug Administration
D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors; D000068698:Tenofovir; D000225:Adenine